We are live on ! Find out more
AEON.WS

AEON Biopharma Inc
AEON.WS

Delisted

AEON.WS was delisted on the 26th of April, 2024.

Back to rankings

55 hedge funds and large institutions have $8.42M invested in AEON Biopharma Inc in 2021 Q4 according to their latest regulatory filings, with 9 funds opening new positions, 5 increasing their positions, 5 reducing their positions, and 2 closing their positions.

New
Increased
Maintained
Reduced
Closed

350% more first-time investments, than exits

New positions opened: 9 | Existing positions closed: 2

15% more funds holding

Funds holding: 48 → 55 (+7)

7% more capital invested

Capital invested by funds: $7.84M → $8.42M (+$576K)

0% more repeat investments, than reductions

Existing positions increased: 5 | Existing positions reduced: 5

Holders
55
Holders Change
+7
Holders Change %
+14.58%
% of All Funds
0.85%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
9
Increased
5
Reduced
5
Closed
2
Calls
$1.1M
Puts
–
Net Calls
+$1.1M
Net Calls Change
+$38K

Top Buyers

Rank Fund Capital Flow
1
Parallax Volatility Advisers
Parallax Volatility Advisers
California
+$127K
2
KC
Kepos Capital
New York
+$85.1K
3
QGA
Q Global Advisors
Texas
+$73.7K
4
WA
Whitebox Advisors
Minnesota
+$55.3K
5
PC
Periscope Capital
Ontario, Canada
+$47.2K

Top Sellers

Rank Fund Capital Flow
1
PAMP
Polar Asset Management Partners
Ontario, Canada
-$62.7K
2
CL
CSS LLC
Illinois
-$46.8K
3
CAC
Cowen and Company
New York
-$12K
4
Citadel Advisors
Citadel Advisors
Florida
-$11.6K
5
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT)
United Kingdom
-$2K
Name Holding Trade Value Shares
Change 		Change in
Stake
RCM
1
Radcliffe Capital Management
Pennsylvania
$2.81M – – –
LP
2
LMR Partners
United Kingdom
$1.94M – – –
AA
3
AQR Arbitrage
Connecticut
$486K – – –
AC
4
Athos Capital
Hong Kong
$289K – – –
ECP
5
Empyrean Capital Partners
California
$238K – – –
Parallax Volatility Advisers
6
Parallax Volatility Advisers
California
$200K +$127K +228,940 +141%
DKCM
7
Davidson Kempner Capital Management
New York
$187K – – –
Citadel Advisors
8
Citadel Advisors
Florida
$173K -$11.6K -20,916 -6%
SCM
9
Segantii Capital Management
Hong Kong
$162K – – –
CC
10
Covalis Capital
United Kingdom
$158K – – –
SCM
11
Shaolin Capital Management
Florida
$138K – – –
PC
12
Periscope Capital
Ontario, Canada
$129K +$47.2K +85,500 +51%
UOC
13
UBS O'Connor
Illinois
$87K +$2.54K +4,593 +3%
Blackstone Inc
14
Blackstone Inc
New York
$85K – – –
CH
15
CVI Holdings
Delaware
$85K – – –
FTCM
16
Fir Tree Capital Management
New York
$85K – – –
TCM
17
Tenor Capital Management
New York
$85K – – –
KC
18
Kepos Capital
New York
$78K +$85.1K +153,920 New
QGA
19
Q Global Advisors
Texas
$68K +$73.7K +133,332 New
PMAM
20
Picton Mahoney Asset Management
Ontario, Canada
$60K – – –
Hudson Bay Capital Management
21
Hudson Bay Capital Management
Connecticut
$51K – – –
Verition Fund Management
22
Verition Fund Management
Connecticut
$51K – – –
WA
23
Whitebox Advisors
Minnesota
$51K +$55.3K +100,000 New
Wells Fargo
24
Wells Fargo
California
$48K – – –
CCA
25
Castle Creek Arbitrage
Colorado
$43K – – –
1
2 3

AEON.WS Hedge Fund Activity: Q4 2021 in Review

55 of the 6,498 institutional investors tracked by Wall St. Rank reported a position in AEON Biopharma Inc (AEON.WS) for Q4 2021, worth a combined $8.42M — up 7.3% from $7.84M a quarter earlier.

Buyers outnumbered sellers: 9 funds opened new AEON.WS positions and 2 closed out — a net gain of 7 holders — while 5 added to existing stakes and 5 trimmed.

The largest buyer was Parallax Volatility Advisers, adding an estimated $127K. The largest seller was Polar Asset Management Partners, cutting an estimated $62.7K.

  • 55 institutional investors held AEON Biopharma Inc (AEON.WS) as of Q4 2021, up from 48 in Q3 2021.
  • Funds reported $8.42M of AEON Biopharma Inc stock for Q4 2021, up 7.3% quarter-over-quarter.
  • 9 funds opened new AEON Biopharma Inc positions in Q4 2021 and 2 closed out, a net change of +7 holders.
  • The largest AEON Biopharma Inc buyer in Q4 2021 was Parallax Volatility Advisers, an estimated $127K added.
  • The largest AEON Biopharma Inc seller in Q4 2021 was Polar Asset Management Partners, an estimated $62.7K sold.

Based on aggregated 13F filings for Q4 2021.